Taiwanese scientists have created the first genetic treatment approved by the EU for L-amino acid decarboxylase (AADC) deficiency, an extremely rare and fatal disorder, they said yesterday.
The treatment, given the trade name Upstaza, was on Wednesday approved for market by the European Medicines Agency, the EU’s main drug regulator, the National Taiwan University Hospital-based research team told a news conference.
AADC deficiency inhibits the secretion of an enzyme that is key to making dopamine, said team leader Hu Wu-liang (胡務亮), who is also the director of the hospital’s pediatrics and genetic medicine departments.
Photo: Yang Yuan-ting, Taipei Times
The disorder primarily manifests in infants and severely impedes their ability to develop speech, walk, sleep or swallow food, with death typically occurring before the age of five, he said.
The condition affects about 700 children in Taiwan, comprising 30 percent of the world’s AADC cases, suggesting that the genetic trait causing the disorder has a strong regional prevalence, Hu said.
As cases are rare in North America and Europe, where most of the world’s drugs are made, there was a lack of impetus among Western drugmakers to develop a treatment for the condition, he said.
In response, Hu launched an initiative to find a cure, and received the university hospital’s approval in his effort, which led to the creation of Upstaza in 2010, he said.
Upstaza is a one-time treatment that introduces a functioning AADC gene to the patient by directly injecting it into the patient’s brain, using modified adeno-associated viruses as the vehicle mechanism, Hu said.
An affected person with the replaced AADC gene would gain the ability to produce dopamine, leading to a partial recovery of bodily functions and providing hope for a normal life, Hu said, adding that the therapy has been proven by a 12-year tracking study.
A two-year-old patient who had been bedridden and unable to speak gained the ability to run, use staircases unassisted and verbally communicate within four years of receiving the treatment, he said.
“Using the technology, the hospital successfully treated the 30 Taiwanese patients [with AADC] to bring hope to their families,” Hu said.
The rights to the drug have been transferred to US-based PTC Therapeutics, which is exploring the possibility of applying Upstaza’s underlying viral and surgical technology to treat other conditions affecting the brain, he said.
Upstaza cannot be used for Parkinson’s disease, as the treatment requires intact neurons to work, Hu added.
An apartment building in New Taipei City’s Sanchong District (三重) collapsed last night after a nearby construction project earlier in the day allegedly caused it to tilt. Shortly after work began at 9am on an ongoing excavation of a construction site on Liuzhang Street (六張街), two neighboring apartment buildings tilted and cracked, leading to exterior tiles peeling off, city officials said. The fire department then dispatched personnel to help evacuate 22 residents from nine households. After the incident, the city government first filled the building at No. 190, which appeared to be more badly affected, with water to stabilize the
Taiwan plans to cull as many as 120,000 invasive green iguanas this year to curb the species’ impact on local farmers, the Ministry of Agriculture said. Chiu Kuo-hao (邱國皓), a section chief in the ministry’s Forestry and Nature Conservation Agency, on Sunday said that green iguanas have been recorded across southern Taiwan and as far north as Taichung. Although there is no reliable data on the species’ total population in the country, it has been estimated to be about 200,000, he said. Chiu said about 70,000 iguanas were culled last year, including about 45,000 in Pingtung County, 12,000 in Tainan, 9,900 in
DEEPER REVIEW: After receiving 19 hospital reports of suspected food poisoning, the Taipei Department of Health applied for an epidemiological investigation A buffet restaurant in Taipei’s Xinyi District (信義) is to be fined NT$3 million (US$91,233) after it remained opened despite an order to suspend operations following reports that 32 people had been treated for suspected food poisoning, the Taipei Department of Health said yesterday. The health department said it on Tuesday received reports from hospitals of people who had suspected food poisoning symptoms, including nausea, vomiting, stomach pain and diarrhea, after they ate at an INPARADISE (饗饗) branch in Breeze Xinyi on Sunday and Monday. As more than six people who ate at the restaurant sought medical treatment, the department ordered the
Taiwan’s population last year shrank further and births continued to decline to a yearly low, the Ministry of the Interior announced today. The ministry published the 2024 population demographics statistics, highlighting record lows in births and bringing attention to Taiwan’s aging population. The nation’s population last year stood at 23,400,220, a decrease of 20,222 individuals compared to 2023. Last year, there were 134,856 births, representing a crude birth rate of 5.76 per 1,000 people, a slight decline from 2023’s 135,571 births and 5.81 crude birth rate. This decrease of 715 births resulted in a new record low per the ministry’s data. Since 2016, which saw
RSS